Globus Medical, Inc. GMED
76.37 USD +5.32 (+7.49%)
At closeNov 9, 2026, 4:26 PM EST
76.37 0.00 0.00%
After hours · Nov 9, 4:26 PM ET
71.91 Day range 76.68
70.40 52-week range 101.40
- YTD
- -12.53%
- 1 year
- -8.96%
Analyst view
Consensus: buy
Buy
Price target (mean) 93.43 +22.3% upside
Now 76.37
- Target (low)
- 75.00
- Target (mean)
- 93.43
- Target (high)
- 110.00
Ratings (0m) 15 10 buy · 5 hold · 0 sell
- Strong buy4
- Buy6
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 14
- 2 months ago 15
- 3 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.29 | 1.23 – 1.32 | 1.28 | +0.7% | 783.40M | -5.2% | 14 |
| Next quarter | 1.19 | 1.09 – 1.28 | 1.12 | +6.1% | 772.44M | +1.7% | 10 |
| Current year | 4.98 | 4.92 – 5.05 | 3.98 | +25.1% | 3.11B | +5.8% | 15 |
| Next year | 5.34 | 5.14 – 5.52 | 4.98 | +7.2% | 3.28B | +5.5% | 15 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 9, 2026 | Truist Securities | Maintained | Buy | Buy |
| Nov 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 6, 2026 | Needham | Maintained | Buy | Buy |
| Nov 6, 2026 | BMO Capital | Downgrade | Outperform | Market Perform |
| Oct 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 7, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 28, 2026 | UBS | Initiated | — | Neutral |
| Jul 16, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 13, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 9, 2026 | BMO Capital | Initiated | — | Outperform |
| Jul 8, 2026 | Stifel | Maintained | Hold | Hold |
| Jun 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| May 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 8, 2026 | Needham | Maintained | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Jan 30, 2026 | Needham | Upgrade | Hold | Buy |
| Jan 9, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 8, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Dec 17, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 17, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 17, 2025 | Freedom Capital Markets | Initiated | — | Hold |
| Dec 2, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Nov 10, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 7, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
